MedTrace Logo

Association of Cystatin C and Bone Mineral Density in Diabetic Patients.

NCT04019938 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-07-15

No results posted yet for this study

Summary

Type 1 diabetes is associated with low bone mineral density(BMD) and type 2 diabetes with normal or high BMD.

Cystatin C is a small molecule that is used to measure kidney function but it's not a troponin of the kidney. It has been associated with many other diseases like atrial fibrillation, depressive symptoms, melanoma, etc.

This crossectional clinical study was done to evaluate the association between Cystatin C and Bone mineral density in both types of diabetic patients.

Conditions

Interventions

RADIATION

Dual-energy X-ray absorptiometry

Cystatin C is measured as a part of routine investigation at the time of admission.

Sponsors & Collaborators

  • Fifth Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Xiao Chun Shu · Fifth affiliated hospital of Sun Yat-Sen University

  • Ashish Shrestha · Fifth affiliated hospital of Sun Yat-Sen University

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-04
Primary Completion
2019-12-25
Completion
2019-12-25

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019938 on ClinicalTrials.gov